These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2257351)

  • 61. Human leukocyte antigens (HLA) and mycobacterial disease.
    de Vries RR; Ottenhoff TH; van Schooten WC
    Springer Semin Immunopathol; 1988; 10(4):305-18. PubMed ID: 3146816
    [No Abstract]   [Full Text] [Related]  

  • 62. Immunotherapy: a new strategy for tuberculosis control?
    Grange JM
    Respir Med; 1997 Jan; 91(1):1-4. PubMed ID: 9068810
    [No Abstract]   [Full Text] [Related]  

  • 63. Mycobacterial cellular antigenic fractions.
    Larson CL; Ribi E
    Am Rev Respir Dis; 1965 Dec; 92(6):49-53. PubMed ID: 5843841
    [No Abstract]   [Full Text] [Related]  

  • 64. Are cytokines our key to immunity against mycobacterial diseases?
    Weir R
    Lepr Rev; 2000 Sep; 71(3):268-9. PubMed ID: 11105485
    [No Abstract]   [Full Text] [Related]  

  • 65. The immunological and epidemiological significance of environmental mycobacteria on leprosy and tuberculosis control.
    Pallen MJ
    Int J Lepr Other Mycobact Dis; 1984 Jun; 52(2):231-45. PubMed ID: 6427125
    [No Abstract]   [Full Text] [Related]  

  • 66. Vaccination and skin test studies on children living in villages with differing endemicity for leprosy and tuberculosis.
    Ghazi Saidi K; Stanford JL; Stanford CA; Dowlati Y; Farshchi Y; Rook GA; Rees RJ
    Int J Lepr Other Mycobact Dis; 1989 Mar; 57(1):45-53. PubMed ID: 2659701
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Towards a vaccine against leprosy.
    Sengupta U
    Lepr India; 1981 Jan; 53(1):88-95. PubMed ID: 7012444
    [No Abstract]   [Full Text] [Related]  

  • 68. Old BCG replaced by new vaccine? Human leukocyte antigens (HLA) and mycobacterial disease.
    de Vries R
    Bull Int Union Tuberc Lung Dis; 1990; 65(2-3):30-1. PubMed ID: 2257351
    [No Abstract]   [Full Text] [Related]  

  • 69. Immunology of leprosy. New developments.
    Ottenhoff TH
    Trop Geogr Med; 1994; 46(2):72-80. PubMed ID: 8079394
    [No Abstract]   [Full Text] [Related]  

  • 70. Under-explored experimental topics related to integral mycobacterial vaccines for leprosy.
    Gormus BJ; Meyers WM
    Expert Rev Vaccines; 2003 Dec; 2(6):791-804. PubMed ID: 14711362
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The cellular and molecular basis of immunity against mycobacterial diseases.
    Colston MJ
    Soc Appl Bacteriol Symp Ser; 1996; 25():33S-39S. PubMed ID: 8972118
    [No Abstract]   [Full Text] [Related]  

  • 72. The immunology of leprosy; unravelling an enigma.
    Choudhuri K
    Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):430-47. PubMed ID: 7594927
    [No Abstract]   [Full Text] [Related]  

  • 73. Prospects for new interventions in the treatment and prevention of mycobacterial disease.
    Young DB; Duncan K
    Annu Rev Microbiol; 1995; 49():641-73. PubMed ID: 8561475
    [TBL] [Abstract][Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.